Amanta Healthcar

50
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
134.23
-3.67 (-2.66%)
BSENSE

May 06

BSE+NSE Vol: 69.62 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
274.00
181.00
93.00
51.38%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
274.00
181.00
93.00
51.38%
Expenditure (Ex Depriciation)
Stock Adjustments
-19.00
-1.00
-18.00
-1,800.00%
Raw Materials Consumed
113.00
93.00
20.00
21.51%
Power & Fuel Cost
22.00
2.00
20.00
1,000.00%
Employee Cost
36.00
10.00
26.00
260.00%
Operating Expenses
23.00
5.00
18.00
360.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
24.00
31.00
-7.00
-22.58%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
2.00
2.00
100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
215.00
150.00
65.00
43.33%
Operating Profit (PBDIT) excl Other Income
59.00
31.00
28.00
90.32%
Other Income
1.00
13.00
-12.00
-92.31%
Operating Profit (PBDIT)
61.00
44.00
17.00
38.64%
Interest
27.00
2.00
25.00
1,250.00%
Profit before Depriciation and Tax
33.00
42.00
-9.00
-21.43%
Depreciation
18.00
1.00
17.00
1,700.00%
Profit Before Taxation & Exceptional Items
14.00
40.00
-26.00
-65.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
14.00
40.00
-26.00
-65.00%
Provision for Tax
4.00
9.00
-5.00
-55.56%
Profit After Tax
10.00
31.00
-21.00
-67.74%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
131.00
-115.00
-87.79%
Profit Available for appropriations
26.00
162.00
-136.00
-83.95%
Appropriations
26.00
162.00
-136.00
-83.95%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
3.71
19.37
-15.66
-80.85%
Profit And Loss - Net Sales
Net Sales 274.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.01% vs 8.19% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.79% vs 9.01% in Mar 2024

Profit And Loss - Interest
Interest 27.95 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -16.92% vs -4.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 10.50 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 189.02% vs 272.14% in Mar 2024